Probiotics Market Size & Share Analysis with 2027 Growth Projections
In 2019, the global probiotics market was valued at USD 48.88 billion and is anticipated to grow to USD 94.48 billion by 2027, registering a compound annual growth rate (CAGR) of 7.9% during the forecast period.

In 2019, the global probiotics market was valued at USD 48.88 billion and is anticipated to grow to USD 94.48 billion by 2027, registering a compound annual growth rate (CAGR) of 7.9% during the forecast period. North America accounted for 16.98% of the global market share that year. The U.S. probiotics market, in particular, is expected to witness substantial expansion, with estimates projecting a market size of USD 17.99 billion by 2032. This growth is being propelled by increasing consumer preference for health-promoting, probiotic-enriched food products that offer immune-boosting benefits.

Rising Consumer Health Awareness

The growing emphasis on preventive healthcare and the demand for natural, safe, and beneficial health products are contributing significantly to the market’s expansion. Efforts by health organizations to educate consumers about probiotics are also enhancing awareness. For instance, the Nutrition Society of Malaysia (NSM) initiated the Probiotics Education Program (PEP) to raise public understanding of the advantages of probiotic consumption.

Information Source: https://www.fortunebusinessinsights.com/industry-reports/probiotics-market-100083 

Scope of the Report

This report offers comprehensive insights into the core market drivers, potential restraints, emerging opportunities, and key challenges expected during the forecast period. It includes detailed regional analyses and market trends that influence global growth. Compiled by industry experts using robust research methodologies, the report also covers the competitive landscape—highlighting strategic developments such as product launches, mergers, partnerships, and acquisitions made by prominent players between 2020 and 2027.

Key Growth Drivers

Growing Demand for Immune-Boosting Solutions

Rising incidences of health conditions like diabetes and obesity are encouraging consumers to seek healthier dietary options. According to the World Health Organization (WHO), global obesity has nearly tripled since 1975. This trend is fueling interest in probiotic products that support immune health. Moreover, technological advancements are enabling brands to better communicate the health benefits of probiotics, further enhancing product adoption worldwide.

Market Segmentation Insights

Supermarkets/Hypermarkets Dominated Sales in 2019

In 2019, supermarkets and hypermarkets contributed to 61.33% of global probiotic product sales. This segment’s dominance can be attributed to the widespread availability of probiotics in these retail outlets, coupled with shopper-friendly features such as discounts, cashback offers, and easy access.

Regional Outlook

Asia-Pacific Remains the Market Leader

The Asia-Pacific region is expected to continue leading the global probiotics market due to a strong cultural preference for fermented foods and beverages, which are known for their digestive health benefits.

In contrast, North America—valued at USD 8.30 billion in 2019—is set to register strong growth over the coming years. This growth is driven by an increase in chronic diseases and continuous investments by major companies in innovative probiotic solutions during the 2020–2027 period.

Competitive Landscape

Innovation as a Core Strategy

Leading companies in the probiotics sector are focusing on innovation to strengthen their market presence. Strategic initiatives such as acquisitions, joint ventures, product introductions, and partnerships are being used to expand distribution networks and drive international growth.

Key Players in the Global Probiotics Market

  • Danone S.A. (France)
  • Lallemand Inc. (Canada)
  • Yakult Honsha Co., Ltd. (Japan)
  • Nestlé S.A. (Switzerland)
  • DuPont (Danisco A/S) (USA)
  • Chr. Hansen (Denmark)
  • Kerry Inc. (Ireland)
  • Post Holdings, Inc. (USA)
  • PepsiCo, Inc. (USA)
  • Evolve Biosystems, Inc. (USA)

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/probiotics-market-100083 

Recent Developments

  • June 2020: Pendulum Therapeutics launched a breakthrough medical probiotic called Pendulum Glucose Control, clinically proven to help lower post-meal blood sugar spikes and reduce A1C levels. This innovation marks a significant step forward in using probiotics for metabolic health management.
disclaimer

What's your reaction?